ALLMedicine™ Glucose Intolerance Center

Sep 15th, 2020 - Fasting hyperglycemia, impaired glucose tolerance, prediabetes, and diabetes are frequently present in patients treated with second-generation antipsychotics (SGAPs) for schizophrenia, bipolar disorder, and other severe mental illnesses. These dru...

Sep 15th, 2020 - This study aims to describe the prevalence of metabolic disturbances in a large cohort of women with PCOS the southeastern Brazil and to compare the findings with other cohorts of Brazilian PCOS women. A retrospective study analyzing clinical and ...

Sep 13th, 2020 - The sphingosin-1-phosphate (S1P) receptor modulator regulates lymphocyte trafficking, resulting in its depletion from circulation which ultimately cause immunosuppression. In this study, we investigated the preventive effect of fingolimod (FTY720)...

Sep 12th, 2020 - Sphingolipid dysregulation is often associated with insulin resistance, while the enzymes controlling sphingolipid metabolism are emerging as therapeutic targets for improving insulin sensitivity. We report herein that sphingosine kinase 2 (SphK2)...

Sep 11th, 2020 - The insulin-degrading enzyme (IDE) is a metalloendopeptidase with a high affinity for insulin. Human genetic polymorphisms in Ide have been linked to increased risk for T2DM. In mice, hepatic Ide ablation causes glucose intolerance and insulin res...

Jul 30th, 2013 - Diabetes and glucose intolerance are common complications of chronic pancreatitis, yet clinical guidance on their detection, classification, and management is lacking. A working group reviewed the medical problems, diagnostic methods, and treatmen...

Sep 15th, 2020 - Fasting hyperglycemia, impaired glucose tolerance, prediabetes, and diabetes are frequently present in patients treated with second-generation antipsychotics (SGAPs) for schizophrenia, bipolar disorder, and other severe mental illnesses. These dru...

Sep 15th, 2020 - This study aims to describe the prevalence of metabolic disturbances in a large cohort of women with PCOS the southeastern Brazil and to compare the findings with other cohorts of Brazilian PCOS women. A retrospective study analyzing clinical and ...

Sep 13th, 2020 - The sphingosin-1-phosphate (S1P) receptor modulator regulates lymphocyte trafficking, resulting in its depletion from circulation which ultimately cause immunosuppression. In this study, we investigated the preventive effect of fingolimod (FTY720)...

Sep 12th, 2020 - Sphingolipid dysregulation is often associated with insulin resistance, while the enzymes controlling sphingolipid metabolism are emerging as therapeutic targets for improving insulin sensitivity. We report herein that sphingosine kinase 2 (SphK2)...

Sep 11th, 2020 - The insulin-degrading enzyme (IDE) is a metalloendopeptidase with a high affinity for insulin. Human genetic polymorphisms in Ide have been linked to increased risk for T2DM. In mice, hepatic Ide ablation causes glucose intolerance and insulin res...

Aug 1st, 2017 - (Reuters Health) - Women who gain substantial amounts of weight after their first pregnancy may be more likely to develop gestational diabetes during their next pregnancy, a Norwegian study suggests. Gestational diabetes is a form of glucose intol...

Apr 27th, 2017 - Action Points Measurement of the biomarker plasma glycated CD59 (pGCD59) was a strong predictor of pregnancy-induced glucose intolerance. Note that in a secondary analysis of 852 participants, large for gestational age newborns were associated wit...

Sep 17th, 2014 - LONDON, Sept 17 (Reuters) - Scientists studying the effects of artificial sweeteners in mice and humans say they have found that eating them may increase the risk of developing glucose intolerance, a risk factor for diabetes. A person receives a t...

Sep 4th, 2014 - Obese children may have a higher risk of developing type 2 diabetes if their mothers had gestational diabetes during pregnancy, according to a recent study. "The ever growing number of women with gestational diabetes (18%) suggests that the future.

May 22nd, 2014 - DENVER – As the nanotechnology field evolves, there are at least three reasons a clinician might prefer to use nanoparticles over conventional drugs, according to Dr. Jack L.